Item Details

FDA Issues [electronic resource]: Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-Ninth Congress, First Session, Risks and Benefits of Raw Milk, February 13, 1985; Emergency Reye's Syndrome Prevention Act of 1985, March 15, 1985; Orphan Drug Act Reauthorization, March 20, 1985

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O., 1985.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.En 2/3:99-26
Description
v, 784 p. : ill., maps, forms ; 24 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1985-HEC-0022
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
  • Includes bibliographies.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details

  • LEADER 02865nam a22003731a 4500
    001 cis2007448805
    006 m d f
    007 cr bn mmmapmmp
    008 091020s1985 dcua sb f000 0 eng d
    043
      
      
    a| n-us---
    074
      
      
    a| 1019-A, 1019-B (microfiche)
    086
    0
      
    a| Y 4.En 2/3:99-26
    088
      
      
    a| Serial no. 99-26 (United States. Congress. House. Committee on Energy and Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Health and the Environment.
    245
    1
    0
    a| FDA issues h| [electronic resource] : b| hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, risks and benefits of raw milk, February 13, 1985; Emergency Reye's Syndrome Prevention Act of 1985, March 15, 1985; Orphan Drug Act reauthorization, March 20, 1985.
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1985.
    300
      
      
    a| v, 784 p. : b| ill., maps, forms ; c| 24 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1985-HEC-0022
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    504
      
      
    a| Includes bibliographies.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    0
    a| Milk contamination z| United States.
    650
      
    0
    a| Reye's syndrome.
    650
      
    0
    a| Drugs x| Law and legislation z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. t| FDA issues w| (OCoLC)12765707 w| gp 86005659
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. t| FDA issues. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 85 H361-95 w| (ProQuest)cis08500603
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1985-HEC-0022 y| Electronic resource (PDF)
    998
      
      
    a| cis08500603
    040
      
      
    a| UMI c| UMI

Availability

Read Online